ISSN: 1025-496X

Journal Home

Eurosurveillance Q1 Unclaimed

European Centre for Disease Prevention and Control (ECDC) Sweden

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Eurosurveillance is a journal indexed in SJR in Medicine (miscellaneous) and Public Health, Environmental and Occupational Health with an H index of 125. It is an CC BY Journal with a Double blind peer review review system The scope of the journal is focused on communicable diseases, public health, infectious diseases, epidemiology, surveillance, prevention. It has an SJR impact factor of 4,145 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,145.

Eurosurveillance focuses its scope in these topics and keywords: surveillance, european, hiv, europe, infection, virus, syphilis, nile, west, recent, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Epidemiology (Q1) Medicine (miscellaneous) (Q1) Public Health, Environmental and Occupational Health (Q1) Virology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

4,145

SJR Impact factor

125

H Index

249

Total Docs (Last Year)

774

Total Docs (3 years)

5276

Total Refs

7086

Total Cites (3 years)

706

Citable Docs (3 years)

11.7

Cites/Doc (2 years)

21.19

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Public Health Q1
Annual Review of Pathology: Mechanisms of Disease Q1
The Lancet Global Health Q1
Annual Review of Clinical Psychology Q1
JAMA - Journal of the American Medical Association Q1

Compare this journals

Aims and Scope

Best articles by citations

Emergence of new recombinant noroviruses GII.p16-GII.4 and GII.p16-GII.2, France, winter 2016 to 2017

Culexmosquitoes are experimentally unable to transmit Zika virus

Longitudinal follow-up of Zika virus RNA in semen of a traveller returning from Barbados to the Netherlands with Zika virus disease, March 2016

Clinical and histopathological features of fatal cases with dengue and chikungunya virus co-infection in Colombia, 2014 to 2015

Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014

Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017

Widespread Usutu virus outbreak in birds in the Netherlands, 2016

Epidemiological investigation and case-control study: a Legionnaires' disease outbreak associated with cooling towers in Warstein, Germany, August-September 2013

Towards a consensus on genotyping schemes for surveillance and outbreak investigations ofCryptosporidium, Berlin, June 2016

Contamination during production of heater-cooler units byMycobacterium chimaerapotential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016

Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016

SHOW MORE ARTICLES

West Nile virus transmission: results from the integrated surveillance system in Italy, 2008 to 2015

Carbapenem-resistant isolates ofAcinetobacter baumanniiin a municipal wastewater treatment plant, Croatia, 2014

Persistent occurrence of serogroup Y/sequence type (ST)-23 complex invasive meningococcal disease among patients aged five to 14 years, Italy, 2007 to 2013

Assessing the potential risk of Zika virus epidemics in temperate areas with establishedAedes albopictuspopulations

Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016

Authors' reply: A norovirus intervariant GII.4 recombinant in Victoria, Australia, June 2016: the next epidemic variant? Reflections and a note of caution

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017

Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe

Tula hantavirus infection in a hospitalised patient, France, June 2015

European public health policies for managing contacts of invasive meningococcal disease cases better harmonised in 2013 than in 2007

Travel-associated and autochthonous Zika virus infection in mainland France, 1 January to 15 July 2016

Letter to the editor: Responding to a call for action - where are we now?